Twist Bioscience Overview
Twist Bioscience Target Price
Analysts' average 12-month price target for Twist Bioscience is $120.
Get informed when a big investor buys or sells
+ FollowShare Price
$188.67
Average Target Price
$121.53
35.6% downside
35.6% downside15 analysts in the last 4 months
High: $212 | Low: $85
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-01 | Guggenheim | $212 |  12.4% upside |  |
| 2026-09-29 | Leerink PartnersPuneet Souda | $190 | 0.7% upside | |
| 2026-09-17 | Leerink PartnersPuneet Souda | $160 | 15.2% downside | |
| 2026-09-09 | UBS | $144 | 23.7% downside | |
| 2026-08-05 | Piper Sandler | $115 | 39% downside | |
| 2026-08-04 | Robert W. Baird | $115 | 39% downside | |
| 2026-07-16 | Leerink PartnersPuneet Souda | $110 | 41.7% downside | |
| 2026-07-14 | Canaccord GenuityKyle Mikson | $120 | 36.4% downside | |
| 2026-07-06 | Evercore ISI | $102 | 45.9% downside | |
| 2026-06-29 | Guggenheim | $107 | 43.3% downside | |
| 2026-06-24 | BarclaysLuke Sergott | $95 | 49.6% downside | |
| 2026-06-15 | Cowen & Co. | $89 | 52.8% downside | |
| 2026-06-15 | Canaccord Genuity | $90 | 52.3% downside | |
| 2026-06-15 | UBS | $89 | 52.8% downside | |
| 2026-06-11 | Piper SandlerDavid Westenberg | $85 | 54.9% downside | |
| 2026-05-22 | Leerink PartnersPuneet Souda | $80 | 57.6% downside | |
| 2026-05-05 | GuggenheimSubbu Nambi | $60 | 68.2% downside | |
| 2026-05-05 | Robert W. BairdCatherine Ramsey Schulte | $65 | 65.5% downside | |
| 2026-05-04 | Barclays | $65 | 65.5% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $55 | 70.8% downside | |
| 2026-02-03 | Robert W. Baird | $50 | 73.5% downside | |
| 2026-02-03 | Evercore ISI | $52 | 72.4% downside | |
| 2026-02-03 | Barclays | $50 | 73.5% downside | |
| 2026-01-05 | Evercore ISI | $42 | 77.7% downside | |
| 2025-12-15 | Barclays | $39 | 79.3% downside | |
| 2025-11-03 | StephensSteven Etoch | $41 | 78.3% downside | |
| 2025-10-02 | Barclays | $40 | 78.8% downside | |
| 2025-08-04 | Evercore ISI | $46 | 75.6% downside | |
| 2025-05-06 | Robert W. BairdCatherine Ramsey Schulte | $44 | 76.7% downside | |
| 2025-03-28 | Guggenheim | $50 | 73.5% downside | |
| 2025-02-04 | Robert W. BairdCatherine Ramsey Schulte | $54 | 71.4% downside | |
| 2025-02-03 | BarclaysLuke Sergott | $58 | 69.3% downside | |
| 2024-09-17 | Robert W. BairdCatherine Schulte | $46 | 75.6% downside | |
| 2024-06-05 | GuggenheimSubbu Nambi | $53 | 71.9% downside | |
| 2024-05-03 | Robert W. BairdCatherine Ramsey Schulte | $40 | 78.8% downside | |
| 2024-01-17 | Goldman SachsMatthew Sykes | $45 | 76.1% downside | |
| 2023-02-05 | BarclaysLuke Sergott | $32 | 83% downside | |
| 2023-01-03 | Evercore ISI | $36 | 80.9% downside | |
| 2022-10-06 | BarclaysLuke Sergott | $45 | 76.1% downside | |